Versant Capital Management’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.1K Buy
1,592
+1,032
+184% +$11.7K ﹤0.01% 1586
2025
Q1
$3.72K Hold
560
﹤0.01% 2133
2024
Q4
$6.18K Buy
+560
New +$6.18K ﹤0.01% 1660